209 related articles for article (PubMed ID: 8258031)
1. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
Bresci G; Parisi G; Banti S
Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
3. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
Zeng Z; Li YY
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
[TBL] [Abstract][Full Text] [Related]
4. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
[TBL] [Abstract][Full Text] [Related]
5. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
[TBL] [Abstract][Full Text] [Related]
6. [Sodium benzoate in portal-systemic-encephalopathy-induced blood ammonia normalization and clinical improvement. Interim report of a double-blind multicenter trial].
Uribe M; Bosques F; Marín E; Cervera E; Gil S; Luis Poo J; Garcia Compeán D; Santoyo R; Huerta E; García-Ramos G; Cadena M; Merikansky A; Robledo J; Cortés M; Guevara A; López N; Aguilar A; Alejandra Ochoa E
Rev Invest Clin; 1990 Jul; 42 Suppl():149-54. PubMed ID: 19256155
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.
Uribe M; Farca A; Márquez MA; Garcĭa-Ramos G; Guevara L
Gastroenterology; 1979 Jun; 76(6):1347-51. PubMed ID: 374177
[TBL] [Abstract][Full Text] [Related]
8. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
Bianchi GP; Marchesini G; Zoli M; Abbiati R; Ferrario E; Fabbri A; Pisi E
Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
[TBL] [Abstract][Full Text] [Related]
10. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.
Watanabe A; Sakai T; Sato S; Imai F; Ohto M; Arakawa Y; Toda G; Kobayashi K; Muto Y; Tsujii T; Kawasaki H; Okita K; Tanikawa K; Fujiyama S; Shimada S
Hepatology; 1997 Dec; 26(6):1410-4. PubMed ID: 9397979
[TBL] [Abstract][Full Text] [Related]
12. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial.
Riggio O; Ariosto F; Merli M; Caschera M; Zullo A; Balducci G; Ziparo V; Pedretti G; Fiaccadori F; Bottari E
Dig Dis Sci; 1991 Sep; 36(9):1204-8. PubMed ID: 1893805
[TBL] [Abstract][Full Text] [Related]
13. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
Strauss E; Tramote R; Silva EP; Caly WR; Honain NZ; Maffei RA; de Sá MF
Hepatogastroenterology; 1992 Dec; 39(6):542-5. PubMed ID: 1483668
[TBL] [Abstract][Full Text] [Related]
14. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
[TBL] [Abstract][Full Text] [Related]
15. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Encephalopathy.
Blei AT; Córdoba J;
Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
[TBL] [Abstract][Full Text] [Related]
17. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
18. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
Shaposhnikova NA
Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
[No Abstract] [Full Text] [Related]
19. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
